Joerg Seebeck

QT-prolonging effects of monoclonal antibody drugs in humans: a systematic review of two literature and a public adverse event database.

Torquil Jackson, Jelena Kondic, Joerg Seebeck, 2015, International journal of clinical pharmacology and therapeutics.

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

A. Ravaud, Y. Vugmeyster, M. Sznol, 2023, Journal for ImmunoTherapy of Cancer.

Digital Commons@Becker Digital

F. Saad, A. Ravaud, A. Armstrong, 2023 .

Digital Commons@Becker Digital

A. Ravaud, Y. Vugmeyster, M. Sznol, 2023 .